Cite
HARVARD Citation
Svanberg, R. et al. (2020). Changes in primary and secondary hemostasis in patients with CLL treated with venetoclax and ibrutinib. Leukemia & lymphoma. 61 (14), pp. 3422-3431. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Svanberg, R. et al. (2020). Changes in primary and secondary hemostasis in patients with CLL treated with venetoclax and ibrutinib. Leukemia & lymphoma. 61 (14), pp. 3422-3431. [Online].